60 related articles for article (PubMed ID: 1719732)
1. [Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage].
Waldhausen P; Kiesewetter H; Leipnitz G; Scielny J; Jung F; Bambauer R; von Blohn G
Acta Med Austriaca; 1991; 18 Suppl 1():52-5. PubMed ID: 1719732
[TBL] [Abstract][Full Text] [Related]
2. [Effect of hydroxyethyl starch solution on kidney function in surgical intensive care patients].
Dehne MG; Mühling J; Sablotzki A; Papke G; Kuntzsch U; Hempelmann G
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Jun; 32(6):348-54. PubMed ID: 9333329
[TBL] [Abstract][Full Text] [Related]
3. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
Staedt U; Hütt M; Herrmann B; Seufzer U; Leweling H
Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery.
Mahmood A; Gosling P; Vohra RK
Br J Surg; 2007 Apr; 94(4):427-33. PubMed ID: 17380548
[TBL] [Abstract][Full Text] [Related]
5. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
[TBL] [Abstract][Full Text] [Related]
6. [Modification of hemorheological parameters in microvascular complications of diabetes].
Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
[TBL] [Abstract][Full Text] [Related]
7. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
8. [Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension].
Heilmann L; Lorch E; Hojnacki B; Müntefering H; Förster H
Infusionstherapie; 1991 Oct; 18(5):236-43. PubMed ID: 1722779
[TBL] [Abstract][Full Text] [Related]
9. Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.
Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Ebihara I; Koide H
Diabetes Metab Res Rev; 2005; 21(1):39-43. PubMed ID: 15386824
[TBL] [Abstract][Full Text] [Related]
10. [Diabetic microangiopathy].
Standl R
Z Gesamte Inn Med; 1993 Mar; 48(3):140-9. PubMed ID: 8475638
[TBL] [Abstract][Full Text] [Related]
11. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
12. Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases.
Treib J; Haass A; Pindur G; Grauer MT; Treib W; Wenzel E; Schimrigk K
Arzneimittelforschung; 1996 Nov; 46(11):1064-6. PubMed ID: 8955865
[TBL] [Abstract][Full Text] [Related]
13. Non-diabetic renal disease in patients with type 2 diabetes mellitus.
Prakash J; Sen D; Usha ; Kumar NS
J Assoc Physicians India; 2001 Apr; 49():415-20. PubMed ID: 11762610
[TBL] [Abstract][Full Text] [Related]
14. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
[TBL] [Abstract][Full Text] [Related]
15. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine and microvascular complications in type 1 diabetes.
Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
[TBL] [Abstract][Full Text] [Related]
17. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
18. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
Peczyńska J; Urban M; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyethylstarch 200 and 240 differently affect aortic distensibility but not viscosity and blood pressure upon acute isovolumic hemodilution.
Caron A; Hacquard M; Audibert G; Cauchois G; Vigneron C; Stoltz JF; Longrois D; Menu P
Clin Hemorheol Microcirc; 2006; 35(4):447-58. PubMed ID: 17148843
[TBL] [Abstract][Full Text] [Related]
20. Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients.
Klemm E; Bepperling F; Burschka MA; Mösges R;
Otol Neurotol; 2007 Feb; 28(2):157-70. PubMed ID: 17255882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
